Abstract
Heavy metals such as arsenic, lead, and cadmium are well-characterized toxicants and heavily regulated in ground and surface waters. However, even metals that are essential nutrients can be hazardous at higher concentrations. These transition metals may be less aggressively regulated due to the perception that they do not pose health risks even in the ppm range. One such metal is manganese, which is highly abundant in many drinking water sources in the United States despite emerging evidence that these metals can pose a threat. Vanadium is more tightly regulated due to its phosphatase inhibition, but also is commonly present in drinking water at > 100 ppb. Herein, we evaluate the effects of 100 M (~5 ppm) manganese (II) and vanadium (V) exposure on cellular proteostasis, using HEK293T cells. We find that cellular manganese exposure destabilizes hundreds of proteins. These include NKRF, a repressor of NF-kB, explaining the known inflammation phenotype associated with manganese exposure. Vanadium, by contrast, stabilizes RNA-binding splicing factors, explaining its known perturbation of RNA splicing. These studies provide evidence that manganese and vanadium can strongly perturb cellular processes, and provide motivation for further study.
Supplementary materials
Title
Supplemental information
Description
Immunoblots addressing HSR response to manganese treatment, silver stains of Hsp40 affinity profiling eluates, volcano plots for Hps40 affinity profiling, whole cell proteomics and comparison to Hsp40 affinity profiling, structural comparison between calculated DHX15 structure in the NRKF-DHX14-XRN2 heterotrimer and the reported crystal structure, and representative PRM traces, and protein sequences used for the NRKF-DHX14-XRN2 heterotrimer structural calculation. (PDF)
Actions
Title
Table S2: Hsp40 Affinity Manganese
Description
Table S2 (.xlsx): Hsp40 affinity TMT-AP-MS results for manganese treatment.
Actions
Title
Table S3: Protein Abundance Manganese
Description
Table S3 (.xlsx): Whole cell proteomics results for manganese treatment.
Actions
Title
Table S4 (.xlsx): PRM CVs
Description
Table S4 (.xlsx): CVs for NKRF peptides used for LiP PRM
Actions
Title
Table S2: Hsp40 Affinity Vanadate
Description
Table S5 (.xlsx): Hsp40 affinity TMT-AP-MS results for vanadate treatment.
Actions
Title
Table S3: Protein Abundance Vanadate
Description
Table S6 (.xlsx): Whole cell proteomics results for vanadate treatment.
Actions